Back to results
US 2020/0048193 A1Published application
Tetracycline compounds
AssigneeTetraphase Pharmaceuticals, Inc.
InventorsXiao-Yi Xiao, Roger B. Clark, Diana Hunt, Cuixiang Sun, Magnus P. Ronn, Wu-Yan Zhang, Minsheng He
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.
Claims7
-60. (canceled)
A compound represented by the following structural formula:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- R4 is selected form H or a —(C1-C6) alkyl;
- R4′ is H or a —(C2-C6) alkyl;
- and
- Et is ethyl
3 more elements
A compound represented the following structural formulas:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.